Does MRI breast "density" (degree of background enhancement) correlate with mammographic breast density?

Journal of Magnetic Resonance Imaging

Volumn 40, Issue 2, 2014, Pages 483-489

  Hansen, Nienke L ^a   Kuhl, Christiane K ^a   Barabasch, Alexandra ^a   Strobel, Kevin ^a   Schrading, Simone ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

background parenchymal enhancement; breast MRI; magnetic resonance imaging; mammographic breast density

Indexed keywords

GADOBUTROL;

ARTICLE; BREAST CANCER; BREAST DENSITY; CANCER SCREENING; CONTRAST ENHANCEMENT; DENSITY; DIGITAL MAMMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOLOGIST; ADULT; AGED; BREAST NEOPLASMS; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DENSITOMETRY; EVALUATION STUDY; MALE; MAMMOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS; VERY ELDERLY;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DENSITOMETRY; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MAMMOGRAPHY; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 84904574851     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24495     Document Type: Article

References (25)

1. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V,. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996; 276: 33-38. (Pubitemid 26231053)
2. Boyd NF, Guo H, Martin LJ,. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356: 227-236. (Pubitemid 46143226)
3. Kuhl CK,. The current status of breast MR imaging. Radiology 2007; 244: 356-378.
4. Morris EA,. Diagnosis breast MR imaging: current status and future directions. Radiol Clin North Am 2007; 45: 863-880. (Pubitemid 47410063)
5. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997; 203: 137-144. (Pubitemid 27142721)
6. King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA,. Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 2011; 260: 50-60.
7. King V, Gu Y, Kaplan JB, Brooks JD, Pike MC, Morris EA,. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol 2012; 22: 2641-2647.
8. Cubuk R, Tasali N, Narin B, Keskiner F, Celik L, Guney S,. Correlation between breast density in mammography and background enhancement in MR mammography. Radiol Med 2010; 115: 434-441.
9. Ko ES, Lee BH, Choi HY, Kim RB, Noh WC,. Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound. Eur J Radiol 2011; 80: 719-723.
10. D'Orsi CJ, Bassett LW, Berg WA, et al. BI-RADS: mammography, 4th edition. In:, D'Orsi CJ, Mendelson EB, Ikeda DM, et al, editors. Breast imaging reporting and data system: ACR BI-RADS-breast imaging atlas. Reston, VA: American College of Radiology; 2003.
11. Checka CM, Chun JE, Schnabel FR, Lee J, Toth H,. The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 2012; 198: 292-295.
12. Stomper PC, D'Souza DJ, DiNitto PA, Arredondo MA,. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR Am J Roentgenol 1996; 167: 1261-1265. (Pubitemid 26376247)
13. Müller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD,. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997; 203: 145-149. (Pubitemid 27142722)
14. Delille JP, Slanetz PJ, Yeh ED, Kopans CB, Garrido L,. Physiologic changes in breast MRI during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 2005; 11: 236-241. (Pubitemid 41026036)
15. Laya MB, Gallagher JC, Schreimann JS, Larson EB, Watson P, Weinstein L,. Effect of post-menopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995; 196: 433-437.
16. Reichenbach JR, Przetak C, Klinger G, Kaiser WA,. Assessment of breast tissue changes on hormonal replacement therapy using MRI: a pilot study. J Comput Assist Tomogr 1999; 23: 407-413. (Pubitemid 29235154)
17. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L,. Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MRI imaging-initial observations. Radiology 2005; 235: 36-41. (Pubitemid 40432232)
18. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW,. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004; 96: 621-628. (Pubitemid 38584986)
19. King V, Goldfarb SB, Brooks JD, et al. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology 2012; 264: 670-678.
20. King V, Kaplan J, Pike MC, et al. Impact of Tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast J 2012; 18: 527-534.
21. Vachon CM, Sellers TA, Carlson EE, et al. Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 2007; 67: 8412-8418. (Pubitemid 47395181)
22. Boyd NF, Martin LJ, Rommens JM, et al. Mammographic density: a heritable risk factor for breast cancer. Methods Mol Biol 2009; 472: 343-360.
23. Potten CS, Watson RJ, Williams GT, et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 1988; 58: 163-170.
24. Wolfe JN,. Breast parenchymal patterns and their changes with age. Radiology 1976; 121 (Pt 1): 545-552.
25. Zeppa R,. Vascular response of the breast to estrogen. J Clin Endocr 1969; 29: 695-700.